Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial
Think of this as a partnershipwe provide the medical expertise, and you bring the commitment to your health goals
226,228 In summary, targeting TFEBthrough gene therapy, mTOR inhibition, or enhancement of autophagy-related protein functionmay represent a promising therapeutic approach to restore autophagy and alleviate the severity of AP
This documentation is available on each product page before any transaction
US$ 29.53
US$ 23.47
US$ 20.48
US$ 24.53
US$ 24.25
US$ 26.19
US$ 22.71
US$ 28.48
)
